Actively Recruiting
Freiburg TIPS Registry
Led by University Hospital Freiburg · Updated on 2026-05-01
2000
Participants Needed
1
Research Sites
599 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Patients with clinically significant portal hypertension allocated to implantation of a transjugular intrahepatic portosystemic shunt (TIPS) at the Department of Medicine II of the University Medical Center Freiburg, Germany will be offered to participate in this prospective observational trial. Clinical and laboratory as well as outcome parameters will be assessed before and within the first 12 months after TIPS implantation following a regular follow-up schedule with clinical visits at the University Medical Center Freiburg. During follow-up visits, serum/plasma samples and peripheral blood mononuclear cells (PBMC) are collected and stored in a associated biobank.
CONDITIONS
Official Title
Freiburg TIPS Registry
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients allocated to TIPS implantation due to clinically significant cirrhotic and non-cirrhotic portal hypertension
You will not qualify if you...
- Withdrawal of written informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University Medical Center Freiburg, Department of Medicine II
Freiburg im Breisgau, Germany, 79106
Actively Recruiting
Research Team
D
Dominik Bettinger, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here